Site Maintenance will take place from 4:00 PM on 2024-04-29 to 9:00 AM on 2024-05-01.
Please do not make any content change during this time, otherwise all the changes will be lost.

Select Publications

Journal articles

Harris AG; Todes-Taylor NR; Petrović N; Murrell DF, 2017, 'The distribution of epidermolysis bullosa in Australia with a focus on rural and remote areas', Australasian Journal of Dermatology, 58, pp. 122 - 125, http://dx.doi.org/10.1111/ajd.12431

Zhao CY; Hao EY; Oh DD; Daniel BS; Martin LK; Su JC; Rodrigues M; Murrell DF, 2017, 'A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients', British Journal of Dermatology, 176, pp. 985 - 992, http://dx.doi.org/10.1111/bjd.15271

Jain SV; Harris AG; Su JC; Orchard D; Warren LJ; McManus H; Murrell DF, 2017, 'The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 31, pp. 692 - 698, http://dx.doi.org/10.1111/jdv.13953

Miloslavsky EM; Naden RP; Bijlsma JWJ; Brogan PA; Brown ES; Brunetta P; Buttgereit F; Choi HK; Dicaire JF; Gelfand JM; Heaney LG; Lightstone L; Lu N; Murrell DF; Petri M; Rosenbaum JT; Saag KS; Urowitz MB; Winthrop KL; Stone JH, 2017, 'Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis', Annals of the Rheumatic Diseases, 76, pp. 543 - 546, http://dx.doi.org/10.1136/annrheumdis-2016-210002

Cust AE; Murrell DF, 2017, 'Increasing prevalence but not incidence of psoriasis in the U.K.', British Journal of Dermatology, 176, pp. 568 - 569, http://dx.doi.org/10.1111/bjd.15331

Kalinska-Bienias A; Jakubowska B; Kowalewski C; Murrell DF; Wozniak K, 2017, 'Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires', Advances in Medical Sciences, 62, pp. 92 - 96, http://dx.doi.org/10.1016/j.advms.2016.07.002

Intong LRA; Choi SD; Shipman A; Kho YC; Hwang SJE; Rhodes LM; Walton JR; Chapman MG; Murrell DF, 2017, 'Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand', International Journal of Women's Dermatology, 3, pp. S1 - S5, http://dx.doi.org/10.1016/j.ijwd.2017.02.002

Yang B; Chen G; Yang Q; Yan X; Zhang Z; Murrell DF; Zhang F, 2017, 'Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire', Health and Quality of Life Outcomes, 15, pp. 31, http://dx.doi.org/10.1186/s12955-017-0594-z

Wijayanti A; Zhao CY; Boettiger D; Chiang YZ; Ishii N; Hashimoto T; Murrell DF, 2017, 'The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: Which one to use?', Acta Dermato-Venereologica, 97, pp. 24 - 31, http://dx.doi.org/10.2340/00015555-2473

Stalder JF; Aubert H; Anthoine E; Futamura M; Marcoux D; Morren MA; Trzeciak M; Szalai Z; Veres K; Deleuran M; Vestergaard C; Boralevi F; Chu CY; De Raeve L; Svensson ; Fölster-Holst R; Buchner M; Takaoka R; Aoki V; Chernyshov P; Chernyshova L; Murrell DF; Zhao C; Mckinster CD; Von Kobyletzky L; Eichenfield L; Totri C; Lio P; Seneschal J; Moret L; Barbarot S, 2017, 'Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score', Allergy: European Journal of Allergy and Clinical Immunology, 72, pp. 1713 - 1719, http://dx.doi.org/10.1111/all.13189

Murrell DF, 2017, 'Why have hospitalization rates for bullous pemphigoid soared?', British Journal of Dermatology, 176, pp. 5 - 6, http://dx.doi.org/10.1111/bjd.15190

Guttman-Yassky E; Yosipovitch G; Murrell D; Hanifin J, 2017, '012 Crisaborole ointment provides early relief of pruritus in two phase 3 clinical trials in patients with mild or moderate atopic dermatitis', Journal of Investigative Dermatology, 137, pp. S194 - S194, http://dx.doi.org/10.1016/j.jid.2017.07.108

Grant-Kels J; Murrell D, 2017, 'To the Associate Editors and Reviewers of the International Journal of Women’s Dermatology and the Board of Directors of the Women’s Dermatologic Society', International Journal of Women's Dermatology, 3, pp. 1 - 2, http://dx.doi.org/10.1016/j.ijwd.2017.01.008

Murrell DF, 2016, 'A lesson learned about predatory journals and their difference from peer-reviewed open-access publishing', International Journal of Women's Dermatology, 2, pp. 113 - 114, http://dx.doi.org/10.1016/j.ijwd.2016.08.004

Kizny Gordon A; McIver C; Kim M; Murrell DF; Taylor P, 2016, 'Clinical application of a molecular assay for the detection of dermatophytosis and a novel non-invasive sampling technique', Pathology, 48, pp. 720 - 726, http://dx.doi.org/10.1016/j.pathol.2016.08.006

Hanna S; Kim M; Murrell DF, 2016, 'Validation studies of outcome measures in pemphigus', International Journal of Women's Dermatology, 2, pp. 128 - 139, http://dx.doi.org/10.1016/j.ijwd.2016.10.003

Kim M; Borradori L; Murrell DF, 2016, 'Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management', Drugs and Aging, 33, pp. 711 - 723, http://dx.doi.org/10.1007/s40266-016-0402-1

Kozera EK; Yang A; Murrell DF, 2016, 'Patient and practitioner satisfaction with tele-dermatology including Australia's indigenous population: A systematic review of the literature', International Journal of Women's Dermatology, 2, pp. 70 - 73, http://dx.doi.org/10.1016/j.ijwd.2016.06.004

Zhao CY; Murrell DF, 2016, 'Blistering diseases in neonates', Current Opinion in Pediatrics, 28, pp. 500 - 506, http://dx.doi.org/10.1097/MOP.0000000000000381

See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L, 2016, 'Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia', Australasian Journal of Dermatology, 57, pp. 167 - 174, http://dx.doi.org/10.1111/ajd.12354

Boulard C; Duvert Lehembre S; Picard-Dahan C; Kern JS; Zambruno G; Feliciani C; Marinovic B; Vabres P; Borradori L; Prost-Squarcioni C; Labeille B; Richard MA; Ingen-Housz-Oro S; Houivet E; Werth VP; Murrell DF; Hertl M; Benichou J; Joly P; Hofmann S; Camaioni B; Didona B; Fania L; Della Torre R; Caux F; Alexandre M; Paul C; Bulai Livideanu C; Delaporte E; Dupuy A; Avenel-Audran M; Schmidt E; Schumacher N; Bagot M; Tancrede-Bohin E; Bouaziz JD; D'Incan M; Quereux G; Skowron F; Beylot-Barry M; Doutre MS; Bedane C; Bernard P; Machet L; Jullien ; Debarbieux S; Dereure O; Hünefeld C; Schanz S; Franck N; Maillard H; Misery L; Sassolas B; Abasq C; Bouyeure AC; Lagoutte P; Ferranti V, 2016, 'Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus', British Journal of Dermatology, 175, pp. 142 - 149, http://dx.doi.org/10.1111/bjd.14405

Zhao CY; Chiang YZ; Murrell DF, 2016, 'Neonatal autoimmune blistering disease: A systematic review', Pediatric Dermatology, 33, pp. 367 - 374, http://dx.doi.org/10.1111/pde.12859

Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson ; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LAA; Graff ALB; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar MLA; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI, 2016, 'Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)', British Journal of Dermatology, 175, pp. 69 - 79, http://dx.doi.org/10.1111/bjd.14773

Zhao CY; Murrell DF, 2016, 'Approach and Management of Autoimmune Blistering Diseases', Current Dermatology Reports, 5, pp. 105 - 114, http://dx.doi.org/10.1007/s13671-016-0140-y

Kim M; Jain S; Harris AG; Murrell DF, 2016, 'Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosa', International Journal of Women's Dermatology, 2, pp. 56 - 59, http://dx.doi.org/10.1016/j.ijwd.2016.04.001

Kim M; Yang A; Murrell DF, 2016, 'Epidermolysis bullosa - Why does a multidisciplinary team approach matter?', Turk Dermatoloji Dergisi, 10, pp. 70 - 77, http://dx.doi.org/10.4274/tdd.2986

Maher NG; Chiang YZ; Badoux X; Vonthethoff LW; Murrell DF, 2016, 'Saggy skin as a presenting sign of angioimmunoblastic T-cell lymphoma', Clinical and Experimental Dermatology, 41, pp. 386 - 389, http://dx.doi.org/10.1111/ced.12773

Murrell DF, 2016, 'What is the true mortality from pemphigus?', British Journal of Dermatology, 174, pp. 1185 - 1186, http://dx.doi.org/10.1111/bjd.14711

Harris AG; Choy C; Pigors M; Kelsell DP; Murrell DF, 2016, 'Cover image: Unpeeling the layers of harlequin ichthyosis', British Journal of Dermatology, 174, pp. 1160 - 1161, http://dx.doi.org/10.1111/bjd.14469

Zhao C; Daniel BS; Murrell DF, 2016, 'Debilitating late outcomes of toxic epidermal necrolysis (TEN): Presentation of 2 cases', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 57, pp. 84 - 84, http://dx.doi.org/10.1111/ajd.12480/pdf

Daniel BS; Hertl M; Werth VP; Eming R; Murrell DF, 2016, 'Erratum to "Severity score indexes for blistering diseases" [Clin Dermatol 2011:30 108-113], DOI: 10.1016/j.clindermatol.2011.03.017', Clinics in Dermatology, 34, pp. 430 - 431, http://dx.doi.org/10.1016/j.clindermatol.2016.03.002

Turczynski S; Titeux M; Pironon N; Cohn HI; Murrell DF; Hovnanian A, 2016, 'Marked intrafamilial phenotypic heterogeneity in dystrophic epidermolysis bullosa caused by inheritance of a mild dominant glycine substitution and a novel deep intronic recessive COL7A1 mutation', British Journal of Dermatology, 174, pp. 1122 - 1125, http://dx.doi.org/10.1111/bjd.14312

Chao L; Gor V; Murrell DF; Kim M; O'Toole E; Ly A; Woodley D; Wysong A; Chen M, 2016, 'Over-expression of periostin is associated with clinical outcomes and poor prognosis in cutaneous squamous cell carcinoma', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 136, pp. S75 - S75, http://dx.doi.org/10.1016/j.jid.2016.02.456

Oh DD; Zhao CY; Murrell DF, 2016, 'A review of case-control studies on the risk factors for the development of autoimmune blistering diseases', Journal of the European Academy of Dermatology and Venereology, 30, pp. 595 - 603, http://dx.doi.org/10.1111/jdv.13386

Zhao CY; Ang RYN; George R; Tan MH; Murrell DF, 2016, 'The quality of dermatology consultation documentation in discharge summaries: a retrospective analysis', International Journal of Women's Dermatology, 2, pp. 23 - 27, http://dx.doi.org/10.1016/j.ijwd.2015.12.003

Draelos ZD; Stein Gold LF; Murrell DF; Hughes MH; Zane LT, 2016, 'Post Hoc analyses of the effect of crisaborole topical ointment, 2% on atopic dermatitis: Associated pruritus from phase 1 and 2 clinical studies', Journal of Drugs in Dermatology, 15, pp. 172 - 176

Cestari T; Prati C; Menegon DB; Prado Oliveira ZN; Machado MCR; Dumet J; Nakano J; Murrell DF, 2016, 'Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese', International Journal of Dermatology, 55, pp. e94 - e99, http://dx.doi.org/10.1111/ijd.12819

Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P, 2016, 'Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study', Australasian Journal of Dermatology, 57, pp. 24 - 28, http://dx.doi.org/10.1111/ajd.12295

Wong V; Hill SF; Kim M; Tran K; Murrell DF, 2016, 'Cover Image: The many faces of sarcoidosis', British Journal of Dermatology, 175, pp. 1111 - 1112, http://dx.doi.org/10.1111/bjd.14981

Miller IM; Vinding G; Zarchi K; Esmann S; Murrell DF; Jemec GB, 2016, 'Differences in disease-specific quality of life in patients with actinic keratosis in Australia and Denmark', Acta Dermatovenerologica Croatica, 24, pp. 25 - 28, http://hrcak.srce.hr/file/230721

Mellerio JE; Robertson SJ; Bernardis C; Diem A; Fine JD; George R; Goldberg D; Halmos GB; Harries M; Jonkman MF; Lucky A; Martinez AE; Maubec E; Morris S; Murrell DF; Palisson F; Pillay EI; Robson A; Salas-Alanis JC; McGrath JA, 2016, 'Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: Best clinical practice guidelines', British Journal of Dermatology, 174, pp. 56 - 67, http://dx.doi.org/10.1111/bjd.14104

Martins VL; Caley MP; Moore K; Szentpetery Z; Marsh ST; Murrell DF; Kim MH; Avari M; McGrath JA; Cerio R; Kivisaari A; Kähäri VM; Hodivala-Dilke K; Brennan CH; Chen M; Marshall JF; O'Toole EA, 2016, 'Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC', Journal of the National Cancer Institute, 108, http://dx.doi.org/10.1093/jnci/djv293

Chaptini C; Casey G; Harris AG; Wattchow D; Gordon L; Murrell DF, 2015, 'Botulinum toxin A injection for chronic anal fissures and anal sphincter spasm improves quality of life in recessive dystrophic epidermolysis bullosa', International Journal of Women's Dermatology, 1, pp. 167 - 169, http://dx.doi.org/10.1016/j.ijwd.2015.08.002

Murrell DF, 2015, 'Burden of disease scoring in epidermolysis bullosa', British Journal of Dermatology, 173, pp. 1357 - 1358, http://dx.doi.org/10.1111/bjd.14246

Tan JCK; Murrell DF; Hersch MI, 2015, 'Genetic screening for human leukocyte antigen alleles prior to carbamazepine treatment', Journal of Clinical Neuroscience, 22, pp. 1992 - 1993, http://dx.doi.org/10.1016/j.jocn.2015.05.037

Murrell DF, 2015, 'Crisaborole Topical Ointment 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept Study.', Journal of Drugs in Dermatology, 14, pp. 1108 - 1112

Frew JW; Murrell DF; Haber RM, 2015, 'Fifty shades of yellow: A review of the xanthodermatoses', International Journal of Dermatology, 54, pp. 1109 - 1123, http://dx.doi.org/10.1111/ijd.12945

Sebaratnam DF; Okawa J; Payne A; Murrell DF; Werth VP, 2015, 'Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA', Quality of Life Research, 24, pp. 2257 - 2260, http://dx.doi.org/10.1007/s11136-015-0965-z

Zhao CY; Chiang YZ; Murrell DF, 2015, 'Blisters and erosions affecting the oral cavity, scalp, face, and trunk', Journal of the American Academy of Dermatology, 73, pp. e87 - e88, http://dx.doi.org/10.1016/j.jaad.2015.03.027

Zhao CY; Tran AQT; Lazo-Dizon JP; Kim J; Daniel BS; Venugopal SS; Rhodes LM; Law MG; Murrell DF; Han A, 2015, 'A pilot comparison study of four clinician-rated atopic dermatitis severity scales', British Journal of Dermatology, 173, pp. 488 - 497, http://dx.doi.org/10.1111/bjd.13846


Back to profile page